Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
NewLimit
NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism…
NewLimit
NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism…
TL;DR
Founded: 2021
Headquarters: South San Francisco, California
Focus: Epigenetic reprogramming therapies to extend human healthspan
Employee count: 51
Latest disclosed round: Series B $130M (May 6, 2025) led by Kleiner Perkins
Company Overview
Problem Domain
Age-related disease and cellular aging
Founded
2021
Industry
Biotechnology Research
Funding Track Record
$40 million
$130 million
Investor Signal
“Includes participation from Kleiner Perkins, Nat Friedman, Daniel Gross, Khosla Ventures, Human Capital, Valor Equity Partners, Founders Fund, and Dimension Capital”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,300+
New This Week
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |